Neurological Manifestations in Children Diagnosed With Inflammatory Bowel Disease in Assiut University Child Hospital
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 44
- Primary Endpoint
- Screening for Neurological manifestations among children diagnosed with inflammatory bowel disease in Assiut university children hospital
Study Overview
Brief Summary
screen for neurologic and psychiatric disorders in children and
adolescents with IBD.
Detailed Description
Neurologic symptoms have a great importance in early diagnosis and
treatment preventing major morbidity and later sequelae, especially if they
precede GI symptoms
The prevalence of neurologic manifestations of IBD varies between 0.2% and
36%. Their pathogenesis of neurologic manifestations in IBD consists of 6
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 1 Year to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •patients with IBD aged from from 1 to18 years old.
Exclusion Criteria
- •patients with IBD and aged above 18 years old or below 1 year old
Outcomes
Primary Outcomes
Screening for Neurological manifestations among children diagnosed with inflammatory bowel disease in Assiut university children hospital
Time Frame: during the period from January 2026 to January 2027.
Neurologic symptoms have a great importance in early diagnosis and treatment preventing major morbidity and later sequelae, especially if they precede GI symptoms The prevalence of neurologic manifestations of IBD varies between 0.2% and 36%. Their pathogenesis of neurologic manifestations in IBD consists of 6 mechanisms: 1.malabsorption and nutritional deficiency 2.metabolic agents 3.infections complicating immune suppression 4.side effects of medications or iatrogenic as a surgical complication 5.thromboembolism 6.immunological factors UC patients are similar to or higher than CD patients in the probability of neurologic symptoms. Neurologic manifestations and complications include: headache, dizziness, hypotonia, ADHD, tics, sensory complaints, seizures, neuropsychiatric disorders, peripherial neuropathy, meningitis, vestibular dysfunction, idiopathic IC hypertension, cerebral vasculitis, demyelinating disorders and migraine
screen for neurologic and psychiatric disorders in children and adolescents with IBD.
Time Frame: 1 year
Secondary Outcomes
No secondary outcomes reported
Investigators
Bishoy Shehata Fahim
Doctor
Assiut University